SCHEMBL4003205

SCHEMBL4003205

CCCCCN(CCCCC)c1ccc(C=O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.66
ALDH1A3 P47895 4/20 0.66
ALDH3A1 P30838 3/20 0.66
CYP2A6 P11509 1/20 0.48
CYP2A13 Q16696 1/20 0.48
AR P10275 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
CNR2 P34972 4/20 0.42
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
CRHBP P24387 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10438443 0.98 ALDH1A3 (0.63) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL609500 0.98 ALDH1A3 (0.63) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL1166127 0.98 ALDH1A3 (0.63) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL9448811 0.98 ALDH1A3 (0.63) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL26836706 0.98 ALDH1A1 (0.63) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL9875023 0.98 ALDH1A3 (0.63) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL9442184 0.96 ALDH3A1 (0.61) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL10612062 0.96 ALDH1A1 (0.66) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL8626518 0.95 ALDH1A1 (0.63) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13
SCHEMBL420424 0.94 ALDH1A1 (0.68) ALDH1A1ALDH1A3ALDH3A1CYP2A6CYP2A13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7524991-B2 Organic electroluminescent devices, aminostyrylnaphthalene compounds and synthesis intermediates thereof, and production processes of the same SONY CORPORATION (JP) 2009-04-28 US claimed
US-7364804-B2 Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-04-29 US claimed
US-20080051607-A1 ORGANIC ELECTROLUMINESCENT DEVICES, AMINOSTYRLNAPHTHALENE COMPOUNDS AND SYNTHESIS INTERMEDIATES THEREOF, AND PRODUCTION PROCESSES OF THE SAME SONY CORPORATION (JP) 2008-02-28 US claimed
EP-1090911-B1 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORP (JP) 2006-08-30 EP claimed
US-7087310-B2 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-08-08 US claimed
EP-1092704-B1 Bis (aminostyryl) naphtalene compounds, synthesis intermediates thereof, and process for production thereof SONY CORP (JP) 2006-03-08 EP claimed
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2005-11-24 US claimed
US-20050215811-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION 2005-09-29 US claimed
US-6897341-B2 Bis(aminostyryl)naphthalene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2005-05-24 US claimed
US-20050048315-A1 Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2005-03-03 US claimed
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2003-08-07 US claimed
US-20030073863-A1 Bis (aminostyryl) benzene compounds and synthetic intermediates thereof, and process for preparing the compounds and intermediates ICHIMURA MARI (JP) 2003-04-17 US claimed
US-20030073867-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof JOLED INC. (JP) 2003-04-17 US claimed
US-20030069448-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for producion thereof JOLED INC. (JP) 2003-04-10 US claimed
US-20030069437-A1 Bis (aminostyryl) benzene compunds and synthetic intermediates thereof, and process for preparing the compounds and intermediates JOLED INC. (JP) 2003-04-10 US claimed
US-20030060652-A1 Bis (aminostyryl) benzene compounds and synthetic intemediates thereof, and process for preparing the compounds and intermediates ICHIMURA MARI (JP) 2003-03-27 US claimed
US-6525212-B1 Reacting 4-(N,N-diaryl)aminobenzaldehyde and diphosphonic acid ester or diphosphonium salt SONY CORPORATION (JP) 2003-02-25 US claimed
EP-1191015-A1 AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH Sony Corporation (JP) 2002-03-27 EP claimed
EP-1092704-A2 Bis (aminostyryl) naphtalene compounds, synthesis intermediates thereof, and process for production thereof SONY CORPORATION (JP) 2001-04-18 EP claimed
EP-1090911-A2 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2001-04-11 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050258743-A1 Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof AASDHPPT, AADAT, ALDH7A1 ALDH1A1 1220/4885ALDH1A3 2257/4885ALDH3A1 1082/4885
US-20080051607-A1 ORGANIC ELECTROLUMINESCENT DEVICES, AMINOSTYRLNAPHTHALENE COMPOUNDS AND SYNTHESIS INTERMEDIATES THEREOF, AND PRODUCTION PROCESSES OF THE SAME ASNS, RPS24, L1CAM ALDH1A1 798/4885ALDH1A3 286/4885ALDH3A1 919/4885
US-20030060652-A1 Bis (aminostyryl) benzene compounds and synthetic intemediates thereof, and process for preparing the compounds and intermediates INTS6, IDH3B, IDH3A ALDH1A1 531/4885ALDH1A3 1224/4885ALDH3A1 463/4885
US-20030073863-A1 Bis (aminostyryl) benzene compounds and synthetic intermediates thereof, and process for preparing the compounds and intermediates DDC, CCNB1, AASDHPPT ALDH1A1 1346/4885ALDH1A3 2650/4885ALDH3A1 842/4885
US-20050215811-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof DDC, DHPS, RB1 ALDH1A1 1094/4885ALDH1A3 1428/4885ALDH3A1 897/4885
US-20030149290-A1 AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF AASDHPPT, AADAT, ALDH7A1 ALDH1A1 847/4885ALDH1A3 1868/4885ALDH3A1 971/4885
US-20030069448-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for producion thereof DHPS, DDC, AASDHPPT ALDH1A1 554/4885ALDH1A3 868/4885ALDH3A1 611/4885
US-20050048315-A1 Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative SLC19A2, CYP1A1, SLC29A1 ALDH1A1 38/4885ALDH1A3 368/4885ALDH3A1 98/4885
US-20030069437-A1 Bis (aminostyryl) benzene compunds and synthetic intermediates thereof, and process for preparing the compounds and intermediates DDC, AASDHPPT, DHPS ALDH1A1 1431/4885ALDH1A3 3057/4885ALDH3A1 1094/4885
US-20030073867-A1 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof DDC, DHPS, AASDHPPT ALDH1A1 584/4885ALDH1A3 809/4885ALDH3A1 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.